FDA Inspection 971865 — Geisinger Medical Center Blood Bank
The FDA completed an inspection of Geisinger Medical Center Blood Bank on May 11, 2016 in Danville, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 11, 2016
- Fiscal Year
- 2016
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Danville, PA (United States)